Latest News About Glyphosate

Here’s the latest on glyphosate based on recent reporting up to April 2026.

• Key development: A long-standing 25-year-old study on glyphosate safety was retracted in early 2026, renewing debates about cancer risk and prompting calls for renewed EPA review (U.S. coverage notes the retraction and ongoing regulatory scrutiny). This has increased attention on how studies are used in risk assessments and whether additional data should influence labeling and usage guidelines.[1]

• Regulatory and legal context: The U.S. EPA has maintained that glyphosate is safe when used as directed, but faces pressure from advocacy groups and litigation to reassess its carcinogenic potential and environmental impact. Some reports indicate ongoing or renewed reviews under federal pesticide laws, with agencies signaling intent to revisit risk assessments beyond the retracted study. Separately, there are high-profile legal battles and Supreme Court considerations around liability protections for manufacturers, which influence regulatory risk communication.[2][3]

• International and health-system responses: There have been calls in Canada and other jurisdictions for independent reviews or precautionary pauses while safety data are re-examined in light of the retraction and subsequent studies. Canadian outlets covered the retraction and discussed potential shifts in Health Canada’s stance or ongoing review processes. Global pesticide watchdogs and science-focused outlets continue to publish updates on new findings, risk assessments, and policy debates around glyphosate and related compounds.[4][6][8]

• Research and public discourse: Independent and industry-linked analyses continue to surface, with some outlets highlighting methodological debates about key studies and others emphasizing the broader public health and environmental questions raised by pervasive glyphosate use on crops, including GM crops. Expect ongoing discussions around cancer risk signals, exposure, and regulatory thresholds in various regions.[3][6]

• Practical implications for consumers and farmers: In light of evolving safety reviews, farmers may face shifting guidance on application practices, pre-harvest intervals, and buffer zones, while consumers could see continued labeling debates and potential changes to product approvals or usage restrictions depending on jurisdiction. The overall trend is toward greater precaution and more explicit risk communication if additional data strengthen concerns.[1][2]

Illustration: Expect a cycle of new safety assessments, retractions or confirmations of key studies, regulatory re-evaluations, and potential court actions to continue shaping glyphosate policy in 2026 and beyond.[2][1]

Citations:

• A study retraction and calls for EPA reassessment.[1]
• EPA reviews and regulatory pressure context.[2]
• Canadian response to retraction and safety reviews.[4]
• GMWatch and broader update coverage on glyphosate findings and litigation context.[6][3]